// App-Quantinova.ai

: Ultrasensitive Duplex Sequencing of Pretreatment ABL1 Kinase Domain Mutations in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Nicholas J Short

Principal Investigators

  • Hagop M. Kantarjian

  • Koji Sasaki

  • Farhad Ravandi

  • Jorge E. Cortes

  • Marina Y. Konopleva

  • Ghayas C. Issa

  • Rashmi Kanagal-Shamanna

  • Steven M. Kornblau

  • Guillermo Garcia-Manero

  • Victor Rivera

  • Rebecca E. Garris

  • Jesse Salk

  • Justin Prichard

  • Jerald P. Radich

  • Elias J. Jabbour

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Takeda Oncology, Cambridge, MA.

  • University of Washington, Seattle, WA

  • The Pennsylvania State University, Philadelphia, PA

  • Department of Medicine/Division of Hematology, University of Washington, Seattle, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved